IRA Litigation Hurdles Clarified With Ruling In Chamber Of Commerce Suit

Drug manufacturers will have to participate in the Medicare drug price negotiation process for the foreseeable future. Judge Newman's finding that participation in Medicare is voluntary could defeat constitutional challenges to the program and have an impact on other cases. 

Gavel labyrinth
Drug makers face difficulties in legal battle over Medicare drug price negotiation program • Source: Shutterstock

More from Medicare

More from Government Payers